Letter to the Editor: Statins as potential confounding factors to investigate the association between the use of GLP-1 receptor agonists and risk of HCC

Hepatology. 2024 Jun 1;79(6):E169-E170. doi: 10.1097/HEP.0000000000000812. Epub 2024 Mar 5.

Authors

Zheng Li¹, Yi Zhang¹, Ying Li¹, Jie Lan¹, Yuzhu Hu¹, Jiayun Yu¹, Qianqian Meng², Bingwen Zou¹

Affiliations

¹ Department of Radiation Oncology, Division of Thoracic Tumor Multimodality Treatment and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
² Department of Radiotherapy Physics and Technology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.

PMID: 38441957
DOI: 10.1097/HEP.0000000000000812

No abstract available

Publication types

Letter

MeSH terms

Carcinoma, Hepatocellular* / chemically induced
Carcinoma, Hepatocellular* / epidemiology
Confounding Factors, Epidemiologic
Glucagon-Like Peptide-1 Receptor Agonists*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Hypoglycemic Agents / adverse effects
Hypoglycemic Agents / therapeutic use
Liver Neoplasms* / epidemiology
Risk Factors